Parus Finance (UK)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.38M | Sell |
11,259
-788
| -7% | -$307K | 1.25% | 16 |
|
|
2025
Q1 | $5.24M | Sell |
12,047
-359
| -3% | -$156K | 1.79% | 15 |
|
|
2024
Q4 | $4.58M | Buy |
12,406
+30
| +0.2% | +$11.1K | 1.43% | 19 |
|
|
2024
Q3 | $6.44M | Sell |
12,376
-3,860
| -24% | -$2.01M | 2.07% | 15 |
|
|
2024
Q2 | $8.8M | Buy |
16,236
+602
| +4% | +$326K | 2.54% | 14 |
|
|
2024
Q1 | $8.11M | Sell |
15,634
-1,221
| -7% | -$633K | 3.05% | 12 |
|
|
2023
Q4 | $7.95M | Buy |
16,855
+417
| +3% | +$197K | 4.13% | 10 |
|
|
2023
Q3 | $7.16M | Sell |
16,438
-1,635
| -9% | -$712K | 4.46% | 10 |
|
|
2023
Q2 | $8.03M | Sell |
18,073
-722
| -4% | -$321K | 3.32% | 9 |
|
|
2023
Q1 | $8.64M | Buy |
18,795
+450
| +2% | +$207K | 5.17% | 5 |
|
|
2022
Q4 | $9.41M | Sell |
18,345
-490
| -3% | -$251K | 6.39% | 6 |
|
|
2022
Q3 | $8.56M | Buy |
18,835
+665
| +4% | +$302K | 7.43% | 5 |
|
|
2022
Q2 | $8.77M | Buy |
18,170
+296
| +2% | +$143K | 5.21% | 8 |
|
|
2022
Q1 | $8.78M | Sell |
17,874
-5,793
| -24% | -$2.85M | 3.14% | 11 |
|
|
2021
Q4 | $11M | Sell |
23,667
-1,868
| -7% | -$866K | 3.52% | 8 |
|
|
2021
Q3 | $9.52M | Sell |
25,535
-3,880
| -13% | -$1.45M | 2.74% | 14 |
|
|
2021
Q2 | $11.2M | Buy |
29,415
+164
| +0.6% | +$62.6K | 2.72% | 14 |
|
|
2021
Q1 | $10.5M | Buy |
29,251
+1,361
| +5% | +$489K | 2.88% | 11 |
|
|
2020
Q4 | $8.96M | Sell |
27,890
-2,290
| -8% | -$735K | 2.62% | 16 |
|
|
2020
Q3 | $8.11M | Sell |
30,180
-750
| -2% | -$201K | 2.76% | 14 |
|
|
2020
Q2 | $8.13M | Buy |
30,930
+6,870
| +29% | +$1.81M | 3.52% | 12 |
|
|
2020
Q1 | $5.46M | Sell |
24,060
-18,000
| -43% | -$4.09M | 6.08% | 8 |
|
|
2019
Q4 | $12.7M | Buy |
42,060
+12,050
| +40% | +$3.64M | 6.43% | 6 |
|
|
2019
Q3 | $7.21M | Buy |
+30,010
| New | +$7.21M | 4.54% | 8 |
|